Peacock Jonathan M
Insider CIK 1500241 · KITE Director · BLPH President and CEO, Director · AVTR Director · AMGN EVP & CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVTR Avantor, Inc. | A Award | 2025-05-08 | 2025-05-12 | 17,100 | — | $0 | 219,815 | SEC↗ |
| AVTR Avantor, Inc. | P Buy | 2025-04-28 | 2025-04-29 | 8,091 | $12.81 | $103.6K | 202,715 | SEC↗ |
| AVTR Avantor, Inc. | A Award | 2024-05-09 | 2024-05-13 | 8,477 | — | $0 | 194,624 | SEC↗ |
| AVTR Avantor, Inc. | A Award | 2023-05-11 | 2023-05-15 | 9,808 | — | $0 | 186,147 | SEC↗ |
| AVTR Avantor, Inc. | A Award | 2022-05-12 | 2022-05-16 | 6,693 | — | $0 | 176,339 | SEC↗ |
| AVTR Avantor, Inc. | A Award | 2022-04-01 | 2022-04-05 | 1,215 | — | $0 | 169,646 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2021-03-31 | 2021-04-02 | 15,308 | — | $0 | 157,033 | SEC↗ |
| AVTR Avantor, Inc. | A Award | 2021-02-25 | 2021-03-01 | 7,236 | — | $0 | 168,431 | SEC↗ |
| AVTR Avantor, Inc. | A Award | 2020-02-21 | 2020-02-25 | 11,319 | — | $0 | 161,195 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2020-01-23 | 2020-01-27 | 350,000 | — | $0 | 2,225,920 | SEC↗ |
| AVTR Avantor, Inc. | M Exercise deriv | 2019-05-21 | 2019-05-23 | 1,000 | — | $0 | 0 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2019-05-21 | 2019-05-22 | 20,000 | $0.61 | $12.2K | 1,875,920 | SEC↗ |
| AVTR Avantor, Inc. | M Exercise | 2019-05-21 | 2019-05-23 | 117,857 | — | $0 | 142,001 | SEC↗ |
| AVTR Avantor, Inc. | A Award | 2019-05-21 | 2019-05-23 | 14,286 | — | $0 | 24,144 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2019-01-25 | 2019-01-25 | 714,286 | $0.70 | $500.0K | 1,855,920 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2019-01-23 | 2019-01-25 | 227,273 | — | $0 | 1,141,634 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2018-04-02 | 2018-04-03 | 99,010 | — | $0 | 914,361 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 50,000 | $178.65 | $8.93M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 10,000 | $120.77 | $1.21M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 8,810 | $88.79 | $782.2K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 7,000 | $129.13 | $903.9K | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | U Tender | 2017-10-03 | 2017-10-05 | 67,932 | $180.00 | $12.23M | 1,807 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 1,807 | — | $0 | 0 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy deriv | 2017-09-29 | 2017-10-03 | 248,962 | — | $0 | 248,962 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2017-09-29 | 2017-10-03 | 248,962 | — | $0 | 815,351 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2017-09-22 | 2017-09-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KITE Kite Pharma, Inc. | G Gift | 2017-09-13 | 2017-10-05 | 635 | — | $0 | 69,739 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2017-06-28 | 2017-06-30 | 57,972 | — | $0 | 566,389 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 8,810 | — | $0 | 8,810 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-06-20 | 2017-06-22 | 2,410 | — | $0 | 70,374 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2016-12-07 | 2016-12-09 | 588,373 | — | $0 | 588,373 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy deriv | 2016-11-29 | 2016-11-30 | 285,715 | — | $0 | 285,715 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2016-11-29 | 2016-11-30 | 285,715 | — | $0 | 508,417 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2016-06-01 | 2016-06-03 | 1,950 | — | $0 | 67,964 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2016-05-17 | 2016-05-18 | 5,000 | $1.37 | $6.9K | 222,702 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2016-01-25 | 2016-01-27 | 165,975 | — | $0 | 217,702 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2015-12-16 | 2015-12-17 | 12,800 | $2.76 | $35.3K | 51,727 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2015-12-15 | 2015-12-17 | 7,500 | $2.72 | $20.4K | 38,927 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2015-08-19 | 2015-08-20 | 5,000 | $5.48 | $27.4K | 31,427 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2015-06-09 | 2015-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2015-05-20 | 2015-05-22 | 5,560 | $8.69 | $48.3K | 26,427 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2015-03-12 | 2015-03-16 | 16,000 | — | $0 | 16,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2015-03-12 | 2015-03-16 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2015-02-19 | 2015-02-23 | 20,800 | $12.00 | $249.6K | 20,867 | SEC↗ |
| KITE Kite Pharma, Inc. | J Other | 2014-06-25 | 2014-06-27 | 66,014 | $15.30 | $1.01M | 66,014 | SEC↗ |
| AMGN AMGEN INC | F Tax w/h | 2013-10-28 | 2013-10-29 | 13,045 | $116.32 | $1.52M | 94,414 | SEC↗ |
| AMGN AMGEN INC | F Tax w/h | 2013-04-25 | 2013-04-29 | 2,721 | $104.93 | $285.5K | 107,312 | SEC↗ |
| AMGN AMGEN INC | A Award | 2013-01-28 | 2013-01-30 | 7,477 | — | $0 | 109,950 | SEC↗ |
| AMGN AMGEN INC | F Tax w/h | 2012-10-28 | 2012-10-29 | 11,671 | $87.63 | $1.02M | 102,438 | SEC↗ |
| AMGN AMGEN INC | A Award | 2012-04-27 | 2012-05-01 | 8,654 | — | $0 | 114,027 | SEC↗ |